Reliq Health Technologies Announces Medical Advisory Board

- February 20th, 2019

Reliq Health Technologies (TSXV:RHT,OTCQB:RQHTF) has announced it has formed a new medical advisory board and the appointment of the five inaugural members. As quoted in the press release: “We are pleased to announce the appointment of these exceptionally accomplished, internationally respected healthcare innovators to our newly-constituted Medical Advisory Board,” said Dr. Lisa Crossley, CEO of Reliq … Continued

Reliq Health Technologies (TSXV:RHT,OTCQB:RQHTF) has announced it has formed a new medical advisory board and the appointment of the five inaugural members.

As quoted in the press release:

“We are pleased to announce the appointment of these exceptionally accomplished, internationally respected healthcare innovators to our newly-constituted Medical Advisory Board,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies.  “We look forward to leveraging their passion for patient care, diverse clinical expertise and extensive experience with multiple payers and payment models.”

“I am excited and honored to be working with such an impressive group of clinicians, healthcare executives and health policy experts who share Reliq’s commitment to improving health outcomes, reducing healthcare costs and facilitating access to care for complex patients in the community,” said Dr. Richard Sztramko, MD, FRCPC, Reliq’s Chief Medical Officer and Chair of the Medical Advisory Board.

The five inaugural members of the Medical Advisory Board are:

Dr. Matthew Finnegan, MD, FACS, FCCWS – Dr. Finnegan has made considerable contributions to the art and science of wound healing, helping to develop a physician-directed, nurse practitioner-managed, patient-centered wound care model that has become the standard of care.  He currently serves as the Chief, Division of General Surgery at Lourdes Health System in Camden, NJ and as a Clinical Associate Professor of Surgery with Rowan University School of Osteopathic Medicine. Dr. Finnegan is also the Medical Director of Lourdes Medical Associates Surgical Specialists and the surgical consultant at Magee Rehabilitation Center in Philadelphia, PA.  He directs the Lourdes-Magee program to provide care to the most complex wounds in patients with spinal cord injury. The benefits of this program have been presented at national and international forums as a model of clinical excellence.  Previously, Dr. Finnegan served as the Director of the Institute of Wound Healing and Limb Preservation at Cooper University Hospital in Camden, NJ.  He received his MD from Drexel University College of Medicine.

Click here to read the full press release.

  Life Science and Healthcare Investing report cover

Life Science and Healthcare Investing in 2021

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2021 life science outlook report!
 

Leave a Reply